PSJ Web Site
J-STAGE
  Software Requirements
Microsoft Internet Explorer 5.01 or higher and Netscape Navigator 4.75 or higher are recommended.


J.Health Sci., 48(2), 134-139, 2002

Production of Interleukin-6 and Its Implication in Rats after Subcutaneous Injection of Carbon Tetrachloride

Hiroshi Hojo,*, a Tetsuya Kasakura,a Ryoji Zuinen,a Miho Aoki,a Mitsune Yamaguchi,a Toshiyuki Chikuma,a and Masao Satob

aDepartment of Hygienic Chemistry, Showa Pharmaceutical University, 3-3165 Higashitamagawagakuen, Machida, Tokyo 194-8543, Japan and bDepartment of Hygienic Chemistry, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, 180 Nishihamabouji, Yamashiro-machi, Tokushima 770-8514, Japan

Previously, we have reported that interleukin-6 (IL-6) administration reduces hepatic injury caused by carbon tetrachloride (CCl4) and induces the production of antioxidant proteins, manganese superoxide dismutase and metallothionein. In the present study, we examined whether IL-6 was induced endogenously by CCl4 administration in rats, and examined the relationship between the levels of IL-6 production and hepatic injury. Plasma samples were periodically collected after s.c. administration of 5 ml/kg of CCl4 (50%, v/v, in corn oil). IL-6 was significantly produced at 1.5 hr after administration, peaked at 8 hr and gradually decreased thereafter. The activities of hepatic marker enzymes, alanine aminotransferase (ALT) and sorbitol dehydrogenase (SDH) in plasma, gradually increased and peaked at 48 hr. As the ratio of the amount of corn oil to that of carbon tetrachloride was increased in the range of 1 : 0 to 1 : 8 (v/v), IL-6 induction was decreased, while ALT and SDH activities were augmented. When rats were treated with a pharmacological dose of dexamethasone (1 mg/kg), IL-6 production was decreased, but ALT and SDH activities were augmented. IL-6 expression immediately after CCl4 administration is suggested to play some significant role in reducing hepatic injury. These findings should be thoroughly considered when the hepatic injury model is developed based on the s.c. administration of CCl4.